Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray B Resnick

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Human Pathology|June 5, 2012
Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approachMark P Legolvan, Ross J Taliano, Murray B Resnick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcomeDevasis Chatterjee, Edmond Sabo, Rosemarie Tavares, et al.
Pancreas|April 15, 2015
Mucinous cystic neoplasm of the pancreas with increased IgG4+ plasma cells and histopathologic features of autoimmune pancreatitis/IgG4-related diseaseEvgeny Yakirevich, Kammi J Henriksen, Thomas Miner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinomaSvetlana Kondratiev, Edmond Sabo, Evgeny Yakirevich, et al.
Molecular Pharmacology|February 27, 2013
NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cellsXiaoxu Zhou, Dan Li, Murray B Resnick, et al.
Histopathology|August 18, 2018
Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinomaYiang Hui, Shaolei Lu, Hai Wang, et al.
Analytical and Quantitative Cytology and Histology|March 13, 2003
Validation of the novel indices of nuclear pleomorphism, polarity and spatial distribution in the grading of urothelial carcinomaEdmond Sabo, Myriam Gibrat, Yanina Sova, et al.
BMC Cancer|November 14, 2019
Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significanceShaolei Lu, Evgeny Yakirevich, Li Juan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray studyMurray B Resnick, Justin Routhier, Tamako Konkin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 12, 2004
Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray studyMurray B Resnick, Tamako Konkin, Justin Routhier, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Human Pathology|June 5, 2012
Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approachMark P Legolvan, Ross J Taliano, Murray B Resnick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcomeDevasis Chatterjee, Edmond Sabo, Rosemarie Tavares, et al.
Pancreas|April 15, 2015
Mucinous cystic neoplasm of the pancreas with increased IgG4+ plasma cells and histopathologic features of autoimmune pancreatitis/IgG4-related diseaseEvgeny Yakirevich, Kammi J Henriksen, Thomas Miner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinomaSvetlana Kondratiev, Edmond Sabo, Evgeny Yakirevich, et al.
Molecular Pharmacology|February 27, 2013
NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cellsXiaoxu Zhou, Dan Li, Murray B Resnick, et al.
Histopathology|August 18, 2018
Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinomaYiang Hui, Shaolei Lu, Hai Wang, et al.
Analytical and Quantitative Cytology and Histology|March 13, 2003
Validation of the novel indices of nuclear pleomorphism, polarity and spatial distribution in the grading of urothelial carcinomaEdmond Sabo, Myriam Gibrat, Yanina Sova, et al.
BMC Cancer|November 14, 2019
Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significanceShaolei Lu, Evgeny Yakirevich, Li Juan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray studyMurray B Resnick, Justin Routhier, Tamako Konkin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 12, 2004
Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray studyMurray B Resnick, Tamako Konkin, Justin Routhier, et al.
Pageof 11